Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMVT | APLS | CRSP | ||
| Company | Immunovant Inc | Apellis Pharmaceuticals Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 25.73 | 40.67 | 51.75 | ||
| High | 25.73 | 40.79 | 52.22 | ||
| Low | 24.48 | 40.65 | 49.50 | ||
| Latest | 24.50 | 40.79 | 51.22 | ||
| Change | -1.15 | +0.14 | -0.50 | ||
| % Change | -4.48% | +0.34% | -0.97% | ||
| Volume | 1,212,200 | 6,742,200 | 871,700 | ||
| 20-Day Average Volume | 1,440,335 | 9,542,790 | 1,596,450 | ||
| Previous Close | 25.65 | 40.65 | 51.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.47 | 26.92 | 48.28 | ||
| 20-Day Raw Stochastic | 55.61% | 100.00% | 83.63% | ||
| 20-Day Relative Strength | 47.18 | 82.98 | 50.87 | ||
| Weighted Alpha | +48.70 | +16.51 | +17.38 | ||
| Today's Opinion | 24% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 40% Buy | 72% Buy | 72% Sell | ||
| Last Month's Opinion | 64% Buy | 88% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/02/26 | +0.94% since 04/02/26 | +3.45% since 04/02/26 | ||
| Low | 23.93 on 04/07/26 | 40.41 on 04/06/26 | 47.87 on 04/07/26 | ||
| High | 25.81 on 04/09/26 | 40.79 on 04/10/26 | 52.61 on 04/08/26 | ||
| 1-Month | |||||
| %Chg | -4.74% since 03/10/26 | +107.69% since 03/10/26 | -2.99% since 03/10/26 | ||
| Low | 22.79 on 03/20/26 | 16.83 on 03/30/26 | 44.12 on 03/30/26 | ||
| High | 25.96 on 03/11/26 | 40.79 on 04/10/26 | 52.61 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -5.88% since 01/09/26 | +49.41% since 01/09/26 | -4.87% since 01/09/26 | ||
| Low | 22.79 on 03/20/26 | 16.83 on 03/30/26 | 44.12 on 03/30/26 | ||
| High | 29.25 on 02/25/26 | 40.79 on 04/10/26 | 61.76 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +43.86% since 10/10/25 | +62.38% since 10/10/25 | -29.90% since 10/10/25 | ||
| Low | 16.77 on 10/14/25 | 16.83 on 03/30/26 | 44.12 on 03/30/26 | ||
| High | 29.25 on 02/25/26 | 40.79 on 04/10/26 | 75.16 on 10/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,986,534 | 5,214,186 | 4,916,352 | ||
| Shares Outstanding, K | 203,532 | 127,830 | 95,985 | ||
| Annual Sales | 0 | 1,003,780,000 | 3,510,000 | ||
| Annual Net Income | -413,840,000 | 22,390,000 | -581,600,000 | ||
| Last Quarter Sales | 0 | 199,910,000 | 860,000 | ||
| Last Quarter Net Income | -110,640,000 | -58,950,000 | -130,610,000 | ||
| 60-Month Beta | 0.67 | -0.19 | 1.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 02/06/26 | -0.47 on 02/24/26 | -1.37 on 02/12/26 | ||
| Latest Earnings Date | 06/04/26 | 05/06/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 312.69 | 0.00 | ||